Canada markets closed

Seelos Therapeutics, Inc. (SEEL)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
2.4300-0.0400 (-1.62%)
At close: 04:00PM EDT
2.4300 0.00 (0.00%)
After hours: 07:59PM EDT
Currency in USD

Valuation Measures4

Market Cap (intraday) 1.41M
Enterprise Value 11.27M
Trailing P/E 0.01
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)421.90
Price/Book (mrq)N/A
Enterprise Value/Revenue 220.46
Enterprise Value/EBITDA 2.65

Trading Information

Stock Price History

Beta (5Y Monthly) 1.85
52-Week Change 3-99.65%
S&P500 52-Week Change 332.96%
52 Week High 3844.8000
52 Week Low 32.4100
50-Day Moving Average 34.0054
200-Day Moving Average 355.6646

Share Statistics

Avg Vol (3 month) 3532.63k
Avg Vol (10 day) 3284.7k
Shares Outstanding 5581k
Implied Shares Outstanding 6585.78k
Float 8370.48k
% Held by Insiders 10.49%
% Held by Institutions 14.47%
Shares Short (Sept 30, 2024) 4170.89k
Short Ratio (Sept 30, 2024) 40.14
Short % of Float (Sept 30, 2024) 429.52%
Short % of Shares Outstanding (Sept 30, 2024) 429.41%
Shares Short (prior month Aug 30, 2024) 425.34k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3Jan 24, 2019
Ex-Dividend Date 4N/A
Last Split Factor 21:16
Last Split Date 3Sept 27, 2024

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Jun 30, 2024

Profitability

Profit Margin 203.13%
Operating Margin (ttm)-834.84%

Management Effectiveness

Return on Assets (ttm)-261.11%
Return on Equity (ttm)N/A

Income Statement

Revenue (ttm)2.01M
Revenue Per Share (ttm)23.17
Quarterly Revenue Growth (yoy)11.90%
Gross Profit (ttm)N/A
EBITDA N/A
Net Income Avi to Common (ttm)4.09M
Diluted EPS (ttm)351.0400
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)294k
Total Cash Per Share (mrq)0.79
Total Debt (mrq)10.16M
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)0.08
Book Value Per Share (mrq)-135.50

Cash Flow Statement

Operating Cash Flow (ttm)-13.27M
Levered Free Cash Flow (ttm)-34.28M